Dedicated to Excellence in Pharmaceutical Access
TGA, S19A, Special Access Scheme
라이센스가 없는 제품
Pro Pharmaceuticals Group은 Special Access Scheme, Authorized Prescriber 또는 S19a 경로를 통해 공급하는 전 세계에서 공급되는 다수의 무허가 의약품 을 멜버른에 보유하고 있습니다. TGA 광고 규칙으로 인해 웹사이트에 Special Access Scheme 제품을 나열할 수 없지만 제품 요청에 대해 병원에서 연락할 수 있습니다.
이러한 제품은 모두 온도 제어 시설에 보관되며 타사 물류 제공업체를 통해 병원 및 소매 약국에 직접 배포합니다.
Medicine Shortages and TGA S19A Access
Expertise
Partnering with Healthcare Providers
At Pro Pharmaceuticals Group, we specialise in sourcing both licensed and unlicensed pharmaceuticals to address urgent gaps in medicine availability. Our unwavering commitment to patient care drives us to provide comprehensive solutions, including access to TGA S19A-approved medicines that meet pressing healthcare needs. Through our global network of trusted suppliers, we ensure reliable sourcing while maintaining strict regulatory compliance.
Our expertise in navigating the Special Access Scheme allows us to deliver these critical treatments seamlessly, enabling uninterrupted patient care. With a focus on quality, compliance, and efficiency, we bridge gaps in supply to uphold the highest standards of safety.
We understand the significant challenges hospitals, pharmacies, and healthcare organizations face during medicine shortages. Pro Pharmaceuticals Group offers tailored support by providing customized solutions that address the unique needs of patients and healthcare providers.
Our end-to-end services include sourcing, procurement, and compliant delivery and distribution. With robust supply chain management, we ensure reliable access to critical medicines, empowering healthcare providers to deliver uninterrupted care.
Our dedicated team remains focused on ensuring that no patient is left without the treatment they require.
